posted on 2016-02-10, 15:47authored byShuting Sun, Katarzyna M. Błażewska, Anastasia
P. Kadina, Boris A. Kashemirov, Xuchen Duan, James T. Triffitt, James E. Dunford, R. Graham G. Russell, Frank H. Ebetino, Anke J. Roelofs, Fraser P. Coxon, Mark W. Lundy, Charles E. McKenna
A bone
imaging toolkit of 21 fluorescent probes with variable spectroscopic
properties, bone mineral binding affinities, and antiprenylation activities
has been created, including a novel linking strategy. The linking
chemistry allows attachment of a diverse selection of dyes fluorescent
in the visible to near-infrared range to any of the three clinically
important heterocyclic bisphosphonate bone drugs (risedronate, zoledronate,
and minodronate or their analogues). The resultant suite of conjugates
offers multiple options to “mix and match” parent drug
structure, fluorescence emission wavelength, relative bone affinity,
and presence or absence of antiprenylation activity, for bone-related
imaging applications.